Publication Name	World Journal of Virology
Manuscript ID	101693
Country	Germany

Received	2024-09-25 08:27
Peer-Review Started	2024-09-23 13:56
To Make the First Decision
Return for Revision	2024-11-08 05:39
Revised	2024-11-14 13:00
Second Decision	2024-12-03 03:04
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-12-03 10:19
Articles in Press	2024-12-03 10:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-01-02 02:28
Publish the Manuscript Online	2025-06-23 07:18

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Review
Article Title	New frontiers in sickle cell disease: The role of antiviral therapies and emerging drugs in managing viral infections
Manuscript Source	Invited Manuscript
All Author List	Tarun Sahu, Arunita Tushar Jagzape, Meenakshi Sinha, Ramanjan Sinha and Henu Kumar Verma
Funding Agency and Grant Number
Corresponding Author	Henu Kumar Verma, PhD, Department of Lung Health and Immunity, Helmholtz Zentrum Munich, Ingolstädter Landstraße 1, Munich 85764, Bayren, Germany. henu.verma@yahoo.com
Key Words	Sickle cell disease; Viral Infection; Virus; Antiviral; Therapeutics
Core Tip	Sickle cell disease patients are highly susceptible to viral infections due to their immune compromised state. This review highlights the complications associated with viral infections, its treatment plans, and the role of vaccinations in improving results in these patients. Future research is essential to optimize antiviral approaches in this vulnerable population.
Publish Date	2025-06-23 07:18
Citation	<p>Sahu T, Jagzape AT, Sinha M, Sinha R, Verma HK. New frontiers in sickle cell disease: The role of antiviral therapies and emerging drugs in managing viral infections. <i>World J Virol</i> 2025; 14(2): 101693</p>
URL	https://www.wjgnet.com/2220-3249/full/v14/i2/101693.htm
DOI	https://dx.doi.org/10.5501/wjv.v14.i2.101693

Full Article (PDF)	WJV-14-101693-with-cover.pdf
Manuscript File	101693_Auto_Edited_021053.docx
Answering Reviewers	101693-answering-reviewers.pdf
Audio Core Tip	101693-audio.mp3
Conflict-of-Interest Disclosure Form	101693-conflict-of-interest-statement.pdf
Copyright License Agreement	101693-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	101693-non-native-speakers.pdf
Peer-review Report	101693-peer-reviews.pdf
Scientific Misconduct Check	101693-scientific-misconduct-check.png
Scientific Editor Work List	101693-scientific-editor-work-list.pdf
CrossCheck Report	101693-crosscheck-report.pdf